文献速递皮肤肿瘤

肢端雀斑样黑素瘤的差异:超越延迟诊断的因素

Disparities in acral lentiginous melanoma: Factors beyond delayed diagnosis.
PubMed 文献 · J Am Acad Dermatol · 2025-06-23

本研究基于SEER数据库,比较不同种族在四种主要黑素瘤亚型中的诊断时疾病严重程度和黑素瘤特异性死亡风险。黑人肢端雀斑样黑素瘤(ALM)患者与白人患者诊断时疾病严重程度无显著差异,但黑人ALM患者死亡风险显著更高(HR=2.04,95%CI:1.31-3.11)。结论挑战了种族差异主要归因于延迟诊断的假设。

要点

  • 黑人ALM患者诊断时疾病严重程度与白人无显著差异。
  • 黑人ALM患者黑素瘤特异性死亡风险显著高于白人(HR=2.04)。
  • ALM结局差异不能仅用延迟诊断解释,需进一步研究。

核心结论

  • 黑人ALM患者死亡风险显著高于白人,且诊断时疾病严重程度无差异,挑战延迟诊断主导差异的假设。

研究设计与样本

  • 基于SEER数据库提取皮肤黑素瘤病例,比较四种主要组织学亚型中不同种族的诊断时疾病严重程度和黑素瘤特异性死亡风险,校正临床病理和社会经济协变量。

主要发现

  • 黑人与白人ALM患者诊断时疾病严重程度无显著差异。
  • ALM是唯一黑人患者死亡风险显著高于白人的主要亚型(HR=2.04,95%CI:1.31-3.11)。

临床怎么用

  • 临床应认识到黑人ALM患者即使诊断时严重程度与白人相似,死亡风险仍更高,需加强关注和进一步研究。

局限性

  • 非黑人和非白人ALM数据有限,缺乏非美国数据和大型遗传学研究,限制差异全面评估。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Poor melanoma outcomes in people of color are commonly attributed to a higher acral lentiginous melanoma (ALM) burden and delayed diagnosis. OBJECTIVE: To understand the epidemiology of ALM in different racial groups to establish whether outcome disparities are truly driven by delayed diagnosis. METHODS: Cutaneous melanoma cases were extracted from the Surveillance, Epidemiology, and End Results Program database. Disease severity at diagnosis and risk of melanoma-specific death, independent of clinicopathological and socioeconomic covariates, were compared among racial groups in the 4 major melanoma histological subtypes. RESULTS: No significant difference in disease severity at diagnosis was observed between Black and White patients with ALM. Remarkably, ALM was the only major melanoma subtype in which Black patients faced a significantly higher risk of mortality (hazard ratio = 2.04, 95% confidence interval: 1.31-3.11) when compared to White patients. LIMITATIONS: Limited data on ALM in non-Black and non-White patients, and a lack of non-US data and large genetic studies decreased our ability to assess disparities more comprehensively. CONCLUSION: Findings from this study counter previous assumptions that racial disparities in ALM are primarily attributed to delay in diagnosis and socioeconomic challenges, and suggest that more studies are needed to understand the disparity in ALM outcomes among Black patients.

来源:J Am Acad Dermatol,查看原文。版权归原作者所有。

引用

  1. Grant S, Revan D, Tang L, et al. Disparities in acral lentiginous melanoma: Factors beyond delayed diagnosis. J Am Acad Dermatol. 2025. PMID: 40562077. doi:10.1016/j.jaad.2025.06.048

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。